Roche Holding | ROG - Market Capitalization


Roche Holding reported CHF255.78B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Alcon AG USD 29.19B 4.58B Aug/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amgen USD 209.65B 14.21B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Bayer EUR 48.39B 834.21M Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Fresenius EUR 26.29B 3.78B Aug/2026
Fresenius Medical Care EUR 12.42B 1.87B Aug/2026
Genmab DKK 126.96B 109.86B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Lakefront Biotherapeutics EUR 1.61B 115.98M Aug/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 62.37B 43.39B Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Orion EUR 10.15B 316M Jun/2026
Pfizer USD 153.17B 14.73B Aug/2026
Philips EUR 23.09B 615.44M Jun/2026
Recordati EUR 10.65B 209.88M Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025